XRCC1 and neoplasm: Changes in several ECM components known to promote growth of tumour cells [1, 15], such as the collagens COL1A1, COL1A2, and the MMP2 metalloprotease (Figure 4A) were also evident in XRCC1 KD cells, again reflecting an activated fibroblast phenotype.